Mammalian cell culture process
AssigneeGenentech, Inc.
InventorsTina Etcheverry, Thomas Ryll
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenentech, Inc.
InventorsTina Etcheverry, Thomas Ryll
Estimating the term…
The present invention relates to novel process for the preparation of glycoproteins by mammalian cell culture wherein the sialic acid content of the glycoprotein produced is controlled over a broad range of values by manipulating the cell culture environment. The invention provides for processes in which the sialic acid content of the glycoprotein is modified by changes in cell culture parameters which affect cell specific productivity. Preferred embodiments of the invention include cell culture processes in the osmolality of the cell culture is controlled as well as the concentration of a transcription enhancer during the production phase of the cell culture. The invention further provides for novel preparations of soluble type 1 tumor necrosis factor immunoglobulin G1 and their uses in the treatment of inflammatory or immune related disorders.
A process for controlling the amount of sialic acid present on an oligosaccharide side chain of a glycoprotein produced by culture in a mammalian host cell which comprises:
Dependencies are inferred from the claim text.